Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion type Assertion NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_head.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion evidence source_evidence_literature NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion SIO_000772 15342407 NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion wasDerivedFrom befree-20140225 NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.
- NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion wasGeneratedBy ECO_0000203 NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.